HN2001000243A - Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona - Google Patents
Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - trionaInfo
- Publication number
- HN2001000243A HN2001000243A HN2001000243A HN2001000243A HN2001000243A HN 2001000243 A HN2001000243 A HN 2001000243A HN 2001000243 A HN2001000243 A HN 2001000243A HN 2001000243 A HN2001000243 A HN 2001000243A HN 2001000243 A HN2001000243 A HN 2001000243A
- Authority
- HN
- Honduras
- Prior art keywords
- triona
- pirimidin
- type
- metaloproteinase inhibitors
- metaloproteinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
LA PRESENTE INVENCION SE REFIERE A INHIBIDORES DE METALOPROTEINASA DEL TIPO PIRIMIDIN - 2, 4 , 6 - TRIONA, Y A COMPOSICIONES FARMACEUTICAS Y METODOS DE TRATAMIENTO O DE INFLAMACION, CANCER Y OTROS TARSTORNOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24331400P | 2000-10-26 | 2000-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2001000243A true HN2001000243A (es) | 2002-11-07 |
Family
ID=36950891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2001000243A HN2001000243A (es) | 2000-10-26 | 2001-10-24 | Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona |
Country Status (36)
Country | Link |
---|---|
US (2) | US6706723B2 (es) |
EP (1) | EP1332136A2 (es) |
JP (1) | JP2004512327A (es) |
KR (1) | KR20030061825A (es) |
CN (1) | CN1714084A (es) |
AP (1) | AP2001002319A0 (es) |
AR (1) | AR035362A1 (es) |
AU (1) | AU2002210800A1 (es) |
BG (1) | BG107651A (es) |
BR (1) | BR0114917A (es) |
CA (1) | CA2425280A1 (es) |
CR (1) | CR6939A (es) |
CZ (1) | CZ20031069A3 (es) |
EA (1) | EA200300409A1 (es) |
EC (1) | ECSP034568A (es) |
EE (1) | EE200300195A (es) |
GT (1) | GT200100214A (es) |
HN (1) | HN2001000243A (es) |
HR (1) | HRP20030331A2 (es) |
HU (1) | HUP0302337A3 (es) |
IL (1) | IL154946A0 (es) |
IS (1) | IS6749A (es) |
MA (1) | MA26956A1 (es) |
MX (1) | MXPA03003734A (es) |
NO (1) | NO20031852L (es) |
NZ (1) | NZ524774A (es) |
OA (1) | OA12528A (es) |
PA (1) | PA8531501A1 (es) |
PE (1) | PE20020585A1 (es) |
PL (1) | PL362919A1 (es) |
SK (1) | SK4872003A3 (es) |
SV (1) | SV2003000704A (es) |
TN (1) | TNSN01150A1 (es) |
UY (1) | UY26981A1 (es) |
WO (1) | WO2002034726A2 (es) |
ZA (1) | ZA200302192B (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076598A1 (fr) * | 2000-04-11 | 2001-10-18 | Sankyo Company, Limited | Compositions pharmaceutiques stabilisees contenant des bloqueurs des canaux calcium |
MXPA03003734A (es) * | 2000-10-26 | 2003-07-28 | Pfizer Prod Inc | Inhibifores de metaloproteinasa del tipo pirimidin-2, 4, 6-triona. |
DE60236851D1 (en) | 2001-02-14 | 2010-08-12 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
PA8539501A1 (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Compuestos triazolo como inhibidores de mmp |
DOP2002000332A (es) | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
DOP2002000333A (es) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz |
JP2004518726A (ja) | 2001-02-14 | 2004-06-24 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | ベンゾチアジアジンマトリックスメタロプロテイナーゼ阻害剤 |
US6924276B2 (en) | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
US6962922B2 (en) | 2001-10-12 | 2005-11-08 | Warner-Lambert Company Llc | Alkynylated quinazoline compounds |
WO2003032999A1 (en) | 2001-10-12 | 2003-04-24 | Warner-Lambert Company Llc | Alkyne matrix metalloproteinase inhibitors |
US7294624B2 (en) * | 2001-12-20 | 2007-11-13 | Bristol Myers Squibb Company | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
US6936620B2 (en) | 2001-12-20 | 2005-08-30 | Bristol Myers Squibb Company | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
US6894057B2 (en) | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
MXPA04010545A (es) * | 2002-04-26 | 2005-01-25 | Pfizer Prod Inc | Inhibidores de metaloproteinasa de heteroariloxi-aril-espiero-pirimidina-2,4,6-triona n-sustituida. |
NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
MXPA04008563A (es) | 2002-04-26 | 2004-12-06 | Pfizer Prod Inc | Inhibidores de metaloproteinasa de triaril-oxi-aril-espiro-pirimidina-2,4,6-triona. |
JP2005529889A (ja) * | 2002-04-26 | 2005-10-06 | ファイザー・プロダクツ・インク | ピリミジン−2,4,6−トリオンメタロ−プロテイナーゼ阻害剤 |
WO2004014375A2 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Fused bicyclic metalloproteinase inhibitors |
AU2003250466A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
AU2003250470A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidinone fused bicyclic metalloproteinase inhibitors |
JP2006501215A (ja) | 2002-08-13 | 2006-01-12 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | マトリックスメタロプロテイナーゼ阻害剤としての単環式誘導体 |
AU2003253186A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors |
PA8578101A1 (es) | 2002-08-13 | 2004-05-07 | Warner Lambert Co | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz |
WO2004014908A1 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Heterobicylcic metalloproteinase inhibitors |
BR0313384A (pt) | 2002-08-13 | 2005-07-12 | Warner Lambert Co | Derivados de cromona como inibidores de metaloproteinases de matriz |
AU2003249531A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
AU2003250471A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
GB0223249D0 (en) * | 2002-10-08 | 2002-11-13 | Amersham Plc | Improved imaging agents |
WO2004084903A1 (en) * | 2003-03-27 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis |
WO2004084902A1 (en) * | 2003-03-28 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment of chronic wounds |
EP1613269B1 (en) | 2003-04-04 | 2015-02-25 | Incyte Corporation | Compositions, methods and kits relating to her-2 cleavage |
WO2005097133A1 (en) * | 2004-04-01 | 2005-10-20 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
ATE493973T1 (de) | 2004-06-04 | 2011-01-15 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
US20120046309A1 (en) | 2009-05-05 | 2012-02-23 | Northwestern University | Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
RU2400233C1 (ru) * | 2009-07-07 | 2010-09-27 | Общество с ограниченной ответственностью "Вирфарм" | Способ лечения заболеваний печени различного генеза |
KR101301533B1 (ko) * | 2010-02-09 | 2013-09-04 | 한미사이언스 주식회사 | 암세포 성장 억제 효과를 갖는 신규 피리미딘 유도체 |
AP3339A (en) | 2011-03-14 | 2015-07-31 | Boehringer Ingelheim Int | Benzodioxane inhibitors of leukotriene production |
EP2734516B1 (en) * | 2011-07-19 | 2015-06-17 | Boehringer Ingelheim International GmbH | Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
AR091315A1 (es) | 2012-03-06 | 2015-01-28 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la produccion de leucotrieno |
NZ628587A (en) | 2012-03-06 | 2016-07-29 | Boehringer Ingelheim Int | Benzodioxanes in combination with other actives for inhibiting leukotriene production |
JP6256467B2 (ja) | 2012-07-17 | 2018-01-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン生成を阻害するピラゾール誘導体 |
US9433623B2 (en) * | 2012-09-14 | 2016-09-06 | Elizabeth LEVINA | Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi |
TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
US9573957B2 (en) | 2013-07-15 | 2017-02-21 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
WO2015009609A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
AU2022376563A1 (en) | 2021-11-01 | 2023-12-07 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548624A1 (de) | 1995-12-23 | 1997-06-26 | Boehringer Mannheim Gmbh | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
ES2247707T3 (es) * | 1997-06-21 | 2006-03-01 | Roche Diagnostics Gmbh | Derivados del acido barbiturico con actividad antimetastasica y antitumoral. |
DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6265578B1 (en) * | 1999-02-12 | 2001-07-24 | Hoffmann-La Roche Inc. | Pyrimidine-2,4,6-triones |
HN2000000137A (es) * | 1999-08-12 | 2001-02-02 | Pfizer Prod Inc | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas |
MXPA03003734A (es) * | 2000-10-26 | 2003-07-28 | Pfizer Prod Inc | Inhibifores de metaloproteinasa del tipo pirimidin-2, 4, 6-triona. |
-
2001
- 2001-10-17 MX MXPA03003734A patent/MXPA03003734A/es unknown
- 2001-10-17 AU AU2002210800A patent/AU2002210800A1/en not_active Abandoned
- 2001-10-17 SK SK487-2003A patent/SK4872003A3/sk unknown
- 2001-10-17 PL PL01362919A patent/PL362919A1/xx not_active Application Discontinuation
- 2001-10-17 EA EA200300409A patent/EA200300409A1/ru unknown
- 2001-10-17 IL IL15494601A patent/IL154946A0/xx unknown
- 2001-10-17 OA OA1200300122A patent/OA12528A/en unknown
- 2001-10-17 EP EP01978707A patent/EP1332136A2/en not_active Withdrawn
- 2001-10-17 NZ NZ524774A patent/NZ524774A/en unknown
- 2001-10-17 HU HU0302337A patent/HUP0302337A3/hu unknown
- 2001-10-17 KR KR10-2003-7005756A patent/KR20030061825A/ko not_active Application Discontinuation
- 2001-10-17 CA CA002425280A patent/CA2425280A1/en not_active Abandoned
- 2001-10-17 CN CNA018180841A patent/CN1714084A/zh active Pending
- 2001-10-17 EE EEP200300195A patent/EE200300195A/xx unknown
- 2001-10-17 WO PCT/IB2001/001953 patent/WO2002034726A2/en not_active Application Discontinuation
- 2001-10-17 BR BR0114917-2A patent/BR0114917A/pt not_active IP Right Cessation
- 2001-10-17 AP APAP/P/2001/002319A patent/AP2001002319A0/en unknown
- 2001-10-17 CZ CZ20031069A patent/CZ20031069A3/cs unknown
- 2001-10-17 JP JP2002537717A patent/JP2004512327A/ja not_active Withdrawn
- 2001-10-23 UY UY26981A patent/UY26981A1/es not_active Application Discontinuation
- 2001-10-24 AR ARP010104976A patent/AR035362A1/es unknown
- 2001-10-24 PE PE2001001051A patent/PE20020585A1/es not_active Application Discontinuation
- 2001-10-24 HN HN2001000243A patent/HN2001000243A/es unknown
- 2001-10-25 SV SV2001000704A patent/SV2003000704A/es unknown
- 2001-10-25 TN TNTNSN01150A patent/TNSN01150A1/fr unknown
- 2001-10-25 GT GT200100214A patent/GT200100214A/es unknown
- 2001-10-25 US US10/032,837 patent/US6706723B2/en not_active Expired - Fee Related
- 2001-10-26 PA PA20018531501A patent/PA8531501A1/es unknown
-
2003
- 2003-03-17 IS IS6749A patent/IS6749A/is unknown
- 2003-03-19 ZA ZA200302192A patent/ZA200302192B/en unknown
- 2003-03-20 BG BG107651A patent/BG107651A/bg unknown
- 2003-03-26 CR CR6939A patent/CR6939A/es not_active Application Discontinuation
- 2003-04-21 MA MA27114A patent/MA26956A1/fr unknown
- 2003-04-24 NO NO20031852A patent/NO20031852L/no not_active Application Discontinuation
- 2003-04-25 EC EC2003004568A patent/ECSP034568A/es unknown
- 2003-04-28 HR HR20030331A patent/HRP20030331A2/hr not_active Application Discontinuation
-
2004
- 2004-02-13 US US10/778,990 patent/US20050107414A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2001000243A (es) | Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
HN2000000137A (es) | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas | |
PA8572101A1 (es) | Inhibidores de metaloproteinasa de aril-heteroariloxi-ariloxi-pirimidina-2,4,6-triona | |
DE60122335D1 (de) | Zusammensetzung auf der basis polymerer mizellen | |
WO2004005326A3 (de) | Tubulysinkonjugate | |
HN1999000066A (es) | Formulaciones farmaceuticas | |
DE60206137D1 (de) | Kräuterpflanzen enthaltende artzneimittel | |
SV2003001107A (es) | Imidazotriazinas ref.lea 35368 | |
HUP0300590A2 (hu) | Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk | |
HN2001000277A (es) | PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS | |
NI200300045A (es) | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. | |
ATE355104T1 (de) | Haarbehandlungsmittel | |
BR0114912A (pt) | Kahalalide f | |
DE60137069D1 (de) | Arzneizusammensetzungen enthaltend modafinilverbindungen | |
HN1998000091A (es) | Inhibidores de la farnesil transferasa tratamiento del cancer. | |
EA200601238A1 (ru) | Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела | |
WO2005041881A3 (en) | Taxoid-fatty acid conjugates and pharmaceutical compositions thereof | |
BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
CY1111290T1 (el) | Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης | |
HN2001000214A (es) | Alcanosulfonatos de fenoxifenilo | |
CR6940A (es) | Inhibidores de espiropirimidin-2,4,6-triona metaloproteinasa | |
HN1998000056A (es) | Agente farmaceutico | |
HN1998000094A (es) | Composiciones farmaceuticas que tienen actividad supresora del apetito | |
ECSP003412A (es) | Derivados de 3- amino -3-arilpropan - 1 - ol, su preparacion y su uso |